In the previous aegis report, DES was valued at 13 cents, that is 39 cents in the current market.Interesting that the latest valuation of 33 cents is lower. I think the sums don't add up somewhere. MM
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025